Jump to content

Pages with the most revisions

Pharmacopedia
BrowseCategoriesLog in

Showing below up to 50 results in range #951 to #1,000.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Problem:MASH with stage 2-3 fibrosis (2 revisions)
  2. Effect:Pattern recognition suppression (2 revisions)
  3. Effect:Headache (2 revisions)
  4. Effect:Muscle cramps (2 revisions)
  5. Effect:Alertness (2 revisions)
  6. Phenotype:CYP2B6 intermediate metabolizer (2 revisions)
  7. Ascorbic Acid (2 revisions)
  8. Effect:Autonomous voice communication (2 revisions)
  9. Effect:Dehydration (2 revisions)
  10. Phenotype:CYP2C19 intermediate metabolizer (2 revisions)
  11. Effect:Double vision (2 revisions)
  12. Problem:Panic disorder (2 revisions)
  13. Metoclopramide (2 revisions)
  14. Effect:Color shifting (2 revisions)
  15. Problem:Obsessive-compulsive disorder (2 revisions)
  16. Effect:Optical sliding (2 revisions)
  17. Problem:Opioid Use Disorder (2 revisions)
  18. Norethindrone (2 revisions)
  19. Effect:Serious cardiac event (2 revisions)
  20. Problem:Vomiting (2 revisions)
  21. Effect:Growth suppression (2 revisions)
  22. Problem:Hypertension (2 revisions)
  23. Effect:Tactile suppression (2 revisions)
  24. Problem:Posttraumatic Stress Disorder (2 revisions)
  25. Effect:Visual disconnection (2 revisions)
  26. Problem:Functional Neurological Disorder (2 revisions)
  27. Cetirizine (2 revisions)
  28. Effect:Tactile hallucination (2 revisions)
  29. Timolol (2 revisions)
  30. Paper:Test define widget (2 revisions)
  31. Effect:Personality regression (2 revisions)
  32. Problem:Embarrassment (2 revisions)
  33. Torsemide (2 revisions)
  34. Effect:Anticholinergic effects (2 revisions)
  35. Problem:Avoidant/Restrictive Food Intake Disorder (2 revisions)
  36. Insulin Detemir (2 revisions)
  37. Effect:Personal bias suppression (2 revisions)
  38. Problem:Alzheimer disease (2 revisions)
  39. Penicillin V (2 revisions)
  40. Effect:Perception of predeterminism (2 revisions)
  41. Problem:Cardiovascular risk reduction in obesity (2 revisions)
  42. Hydroquinone (2 revisions)
  43. Effect:Personal meaning intensification (2 revisions)
  44. Effect:Diarrhea (2 revisions)
  45. Methimazole (2 revisions)
  46. Effect:Neuroplasticity (2 revisions)
  47. Effect:Anxiolysis (2 revisions)
  48. Phenotype:TPMT intermediate metabolizer (2 revisions)
  49. Rivaroxaban (2 revisions)
  50. Effect:External auditory hallucination (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:MostRevisions"